FERRER PHARMACEUTICAL MAY GET EIB FUNDING FOR BARCELONA-BASED RESEARCH

BY KEITH NUTHALL

THE EUROPEAN Investment Bank (EIB) is considering lending Spain's Grupo Ferrer Internacional Euro 80 million to buld and equip a new pharmaceutical research and development centre in Barcelona. The money would also help cover the Ferrer's R&D spending from 2008 to 2011 on hypnotics/anxiolytics, antibiotics, anti-inflammatory products and cardio-vascular medicines. This progress, said an EIB note, would "bring the group's research infrastructure up to the industry's latest standards and will increase effectiveness and ...


Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.